Alimta

... Lilly reports quarterly loss MARKETPLACE: Classifieds Eli Lilly & Co.

company information Star and news services report January 26, 2005 Eli Lilly and Co.

reported a fourth-quarter loss of $2.4 million and broke even on per-share earnings, primarily due to one-time restructuring costs and taxes on overseas earnings.

Excluding about $990 million in those and other one-time charges, the Indianapolis-based pharmaceutical giant reported net income of $814.3 million, or 75 cents a share, for the three months ending Dec.

31, beating predictions of analysts surveyed by Thomson First Call by one cent.

Revenues rose 5 percent to $3.65 billion from $3.47 billion.

Also driving down operating income in the fourth quarter was a $36 million charge taken to settle a Department of Justice inves...

... Bloomberg.com: U.S.

Updated: New York: Jan 26 17:00London: Jan 26 22:00Tokyo: Jan 27 07:00 : Regions Top Worldwide Regions Asia Australia & New Zealand Canada Europe Germany Japan Latin America U.K.

U.S.

Markets Economy/Politics Commentary Sports Culture RESOURCES: Bloomberg TV Bloomberg Radio Markets U.S.

E-Mail This Story Printer-Friendly Format U.S.

Stocks Advance for Second Day as Texas Instruments, Lilly Shares Gain HealthSouth's Beam Testifies Scrushy Told Him to `Fix' Revenue Shortfall Oil Declines for First Day in Four; U.S.

Supplies Rose More Than Forecast Lilly Has $2.4 Mln Loss on Tax Costs; Sales Rise 5% (Update5) Jan.

26 (Bloomberg) - Eli Lilly & Co.

had a fourth-quarter loss on taxes to return $8 billion in profits to the U.S.

from abroad.

Sales rose 5 percent, boosted by attention-deficit drug Strattera and cancer treatment Gemzar.

The net loss of $2.4 million, Lilly's first in seven years, was less than a cent a share and compared with net income of $747.2 million, or 69 cents, a year earlier.

The recent quarter included $465 million in tax costs on profits repatriated under a one-year tax holiday, the Indianapolis-based company said in a statement today.

Newer medicines such as Strattera, Chief Executive Officer Sidney Taurel has closed sales offices, made plans to cut 1,000 job...

... Eli Lilly Loses 2 4 Million WebProNews Delivered: Search: WebProNews Top Business , Cialis, Cymbalta, Forteo, Strattera, Symbyax, Xigris and Yentreve which contributed $498.7 million to fourth-quarter sales.

"Lilly did about as expected, delivering no big surprises," Cathay Financial analyst Sena Lund said.

According to a Reuters article, "The loss included a charge of $465 million for taxes on Lilly's plans to return $8 billion in past overseas earnings under a new U.S.

law that grants a reduced tax rate on the return of profits held by foreign subsidiaries.

Lilly also took $494 million in charges for a previously announced restructuring and asset writedowns."View All Artic...